APA (7th ed.) Citation

O, N., HP, E., E, O., B, G., S, L., ES, B., . . . PE, L. (2023). Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development. Genome medicine, 15(1), 104. https://doi.org/10.1186/s13073-023-01262-8

Chicago Style (17th ed.) Citation

O, Nikolaienko, et al. "Prenatal BRCA1 Epimutations Contribute Significantly to Triple-negative Breast Cancer Development." Genome Medicine 15, no. 1 (2023): 104. https://doi.org/10.1186/s13073-023-01262-8.

MLA (9th ed.) Citation

O, Nikolaienko, et al. "Prenatal BRCA1 Epimutations Contribute Significantly to Triple-negative Breast Cancer Development." Genome Medicine, vol. 15, no. 1, 2023, p. 104, https://doi.org/10.1186/s13073-023-01262-8.